Melittin induces autophagy to alleviate chronic renal failure in 5/6-nephrectomized rats and angiotensin II-induced damage in podocytes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES Chronic renal failure (CRF) is a complex pathological condition that lacks a cure. Certain Chinese medicines, such as melittin, a major component in bee venom, have shown efficacy in treating CRF patients. On the other hand, the mechanisms underlying the therapeutic effects of melittin are unclear. MATERIALS/METHODS A 5/6 nephrectomy model (5/6 Nx) of renal failure was established on rats for in vivo assays, and mouse podocyte clone 5 (MPC5) mouse podocyte cells were treated with angiotensin II (AngII) to establish an in vitro podocyte damage model. The 24-h urine protein, serum creatinine, and blood urea nitrogen levels were evaluated after one, 2, and 4 weeks. Hematoxylin and eosin staining, Masson staining, and periodic acid-Schiff staining were used to examine the pathological changes in kidney tissues. A cell counting kit 8 assay was used to assess the cell viability. Reverse transcription polymerase chain reaction and Western blot were used to assess the mRNA and protein levels in the cells, respectively. RESULTS In the rat 5/6 Nx, melittin reduced the 24-h urinary protein excretion and the serum creatinine and blood urea nitrogen levels. Furthermore, the renal pathology was improved in the melittin-treated 5/6 Nx rats. Melittin promoted podocin, nephrin, Beclin 1, and the LC3II/LC3I ratio and inhibited phosphorylated mammalian target of rapamycin (mTOR)/mTOR in 5/6 Nx-induced rats and AngII-induced MPC5 mouse podocyte cells. Moreover, inhibiting autophagy with 3-MA weakened the effects of melittin on podocin, nephrin, and the LC3II/LC3I ratio in podocytes. CONCLUSION Melittin may offer protection against kidney injury, probably by regulating podocyte autophagy. These results provide the theoretical basis for applying melittin in CRF therapy.
Abstract
BACKGROUND/OBJECTIVES Chronic renal failure (CRF) is a complex pathological condition that lacks a cure. Certain Chinese medicines, such as melittin, a major component in bee venom, have shown efficacy in treating CRF patients. On the other hand, the mechanisms underlying the therapeutic effects of melittin are unclear. MATERIALS/METHODS A 5/6 nephrectomy model (5/6 Nx) of renal failure was established on rats for in vivo assays, and mouse podocyte clone 5 (MPC5) mouse podocyte cells were treated with angiotensin II (AngII) to establish an in vitro podocyte damage model. The 24-h urine protein, serum creatinine, and blood urea nitrogen levels were evaluated after one, 2, and 4 weeks. Hematoxylin and eosin staining, Masson staining, and periodic acid-Schiff staining were used to examine the pathological changes in kidney tissues. A cell counting kit 8 assay was used to assess the cell viability. Reverse transcription polymerase chain reaction and Western blot were used to assess the mRNA and protein levels in the cells, respectively. RESULTS In the rat 5/6 Nx, melittin reduced the 24-h urinary protein excretion and the serum creatinine and blood urea nitrogen levels. Furthermore, the renal pathology was improved in the melittin-treated 5/6 Nx rats. Melittin promoted podocin, nephrin, Beclin 1, and the LC3II/LC3I ratio and inhibited phosphorylated mammalian target of rapamycin (mTOR)/mTOR in 5/6 Nx-induced rats and AngII-induced MPC5 mouse podocyte cells. Moreover, inhibiting autophagy with 3-MA weakened the effects of melittin on podocin, nephrin, and the LC3II/LC3I ratio in podocytes. CONCLUSION Melittin may offer protection against kidney injury, probably by regulating podocyte autophagy. These results provide the theoretical basis for applying melittin in CRF therapy.
참고문헌 (48)
- Chen TK, "Chronic kidney disease diagnosis and management : a review", JAMA, 322, pp.1294~1304 (2019)
- Bryer JS, "Screening drugs for kidney disease : targeting the podocyte", Cell Chem Biol, 25, pp.126~127 (2018)
- Akyüz Özdemir A, "Factors predisposing to the use of complementary therapies in patients with chronic renal failure", Exp Clin Transplant, 1, pp.64~69 (2018)
- Tagawa A, "Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy", Diabetes, 65, pp.755~767 (2016)
- Guo H, "The interplay of autophagy and oxidative stress in the kidney : what do we know", Nephron, 147, pp.627~642 (2023)
- Xue L, "Liraglutide promotes autophagy by regulating the AMPK", mTOR pathway in a rat remnant kidney model of chronic renal failure, 2019, pp.51, 2305~2313
- Li YY, "Heidihuangwan alleviates renal fibrosis in rats with 5", 6 nephrectomy by inhibiting autophagy, 2022, pp.13, 977284~
- Wang Y, "Traditional Chinese medicine in the treatment of chronic kidney diseases : theories, applications, and mechanisms", Front Pharmacol, 13, pp.917975~ (2022)
- Yoshino T, "Oral Astragalus root supplementation for mild to moderate chronic kidney disease : a self-controlled case-series", Front Pharmacol, 13, pp.775798~ (2022)
- Sun X, "Efficacy and safety of Abelmoschus manihot in treating chronic kidney diseases : a multicentre, open-label and single-arm clinical trial", Phytomedicine, 99, pp.154011~ (2022)
- Li J, "The anti-arthritic effects of synthetic melittin on the complete Freund’s adjuvant-induced rheumatoid arthritis model in rats", Am J Chin Med, 38, pp.1039~1049 (2010)
- An HJ, "The protective effect of melittin on renal fibrosis in an animal model of unilateral ureteral obstruction", Molecules, 21, pp.1137~ (2016)
- Kim JY, "Melittin ameliorates endotoxin-induced acute kidney injury by inhibiting inflammation, oxidative stress, and cell death in mice", Oxid Med Cell Longev, 2021, pp.8843051~ (2021)
- He SD, "Treatment with melittin induces apoptosis and autophagy of Fibroblast-Like Synoviocytes in patients with rheumatoid arthritis", Curr Pharm Biotechnol, 21, pp.734~740 (2020)
- Memariani H, "Melittin as a promising anti-protozoan peptide : current knowledge and future prospects", AMB Express, 11, pp.69~ (2021)
- Aghighi Z, "Melittin ameliorates motor function and prevents autophagy-induced cell death and astrogliosis in rat models of cerebellar ataxia induced by 3-acetylpyridine", Neuropeptides, 96, pp.102295~ (2022)
- Sun Q, "A"Chase and Block"strategy for enhanced cancer therapy with hypoxia-promoted photodynamic therapy and autophagy inhibition based on upconversion nanocomposites", Adv Healthc Mater, 12, pp.e2301087~ (2023)
- Yang RC, "Bone marrow mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis in rat models", BMC Nephrol, 19, pp.335~ (2018)
- Ware K, "Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation", J Am Soc Nephrol, 22, pp.1856~1862 (2011)
- Yang L, "Melittin promotes dexamethasone in the treatment of adjuvant rheumatoid arthritis in rats", Front Pharmacol, 15, pp.1338432~ (2024)
- Naji KM, "Hepatoprotective activity of melittin on isoniazid-and rifampicin-induced liver injuries in male albino rats", BMC Pharmacol Toxicol, 22, pp.39~ (2021)
- Duan X, "Interference of periostin attenuates pathological changes, proinflammatory markers and renal fibrosis in diabetic kidney injury", Genes Genomics, 45, pp.1389~1397 (2023)
- Ji J, "Effect of Kangxianling decoction on expression of TGF-β1", Smads and extracellular matrix deposition, 2019, pp.2019, 5813549~
- Zhang Z, "Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy : blockade of compensatory renin increase", Proc Natl Acad Sci U S A, 105, pp.15896~15901 (2008)
- Moon DO, "Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia", Int Immunopharmacol, 7, pp.1092~1101 (2007)
- Du YR, "Melittin activates TRPV1 receptors in primary nociceptive sensory neurons via the phospholipase A2 cascade pathways", Biochem Biophys Res Commun, 408, pp.32~37 (2011)
- Ding J, "Effects of SKF-96365, a TRPC inhibitor, on melittin-induced inward current and intracellular Ca2+ rise in primary sensory cells", Neurosci Bull, 27, pp.135~142 (2011)
- Fukuyo Y, "Nephrin and Podocin functions are highly conserved between the zebrafish pronephros and mammalian metanephros", Mol Med Rep, 9, pp.457~465 (2014)
- Menon MB, "Beclin 1 phosphorylation-at the center of autophagy regulation", Front Cell Dev Biol, 6, pp.137~ (2018)
- Tanida I, "LC3 and autophagy", Methods Mol Biol, 445, pp.77~88 (2008)
- Kim YC, "mTOR : a pharmacologic target for autophagy regulation", J Clin Invest, 125, pp.25~32 (2015)
- Breyer MD, "The next generation of therapeutics for chronic kidney disease", Nat Rev Drug Discov, 15, pp.568~588 (2016)
- Lee HW, "A podocyte-based automated screening assay identifies protective small molecules", J Am Soc Nephrol, 26, pp.2741~2752 (2015)
- Lin Q, "Podocyte autophagy in homeostasis and disease", J Clin Med, 10, pp.1184~ (2021)
- Mizushima N, "In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker", Mol Biol Cell, 15, pp.1101~1111 (2004)
- Leventhal JS, "Recycling to discover something new : the role of autophagy in kidney disease", Kidney Int, 91, pp.4~6 (2017)
- Li H, "Atg5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2", M arrest and renal fibrosis, 2016, pp.12, 1472~1486
- Andrade L, "Acute kidney injury as a condition of renal senescence", Cell Transplant, 27, pp.739~753 (2018)
- Choi M, "Transferrin-conjugated melittin-loaded l-arginine-coated iron oxide nanoparticles for mitigating beta-amyloid pathology of the 5XFAD mouse brain", Int J Mol Sci, 24, pp.14954~ (2023)
- Karimi G, "Melittin as a safe compound to BALB", c mice immune system; a tiered approach immunotoxicity screening, 2023, pp.23, 377~
- Lv C, "The anti-tumour effect of Mel and its role in autophagy in human hepatocellular carcinoma cells", Am J Transl Res, 11, pp.931~941 (2019)
- Yu JE, "Bee venom triggers autophagy-induced apoptosis in human lung cancer cells via the mTOR signaling pathway", J Oncol, 2022, pp.8916464~ (2022)
- Lv C, "Melittin inhibits the proliferation migration and invasion of HCC cells by regulating ADAMTS9-AS2 demethylation", Toxicon, 222, pp.106996~ (2023)
- Lim HN, "Bee venom and its peptide component melittin suppress growth and migration of melanoma cells via inhibition of PI3K", AKT, Molecules, pp.2019, 24[DOI]
- Jeong YJ, "Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K", Akt, Food Chem Toxicol, pp.2014, 68[DOI]
- Fan XG, "Melittin ameliorates inflammation in mouse acute liver failure via inhibition of PKM2-mediated Warburg effect", Acta Pharmacol Sin, 42, pp.1256~1266 (2021)
- Gu H, "Bee venom and its major component melittin attenuated Cutibacterium acnes-and IGF-1-induced acne vulgaris via inactivation of Akt", mTOR, Int J Mol Sci, pp.2022, 23[DOI]
- Moreira Castro BF, "Low-dose melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis", Curr Res Pharmacol Drug Discov, 3, pp.100107~ (2022)
